NGM·Healthcare·$1.5B·#39 / 520 in Healthcare
HROW Harrow, Inc.
73SOLID
CATEGORY BREAKDOWN
GROWTH58
QUALITY95
STABILITY67
VALUATION68
GOVERNANCE75
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+36.4%
58
> 50% strong
Gross Margin
Revenue retained after direct costs
75.1%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
480.4%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
5.5x
68
< 3x strong
Rule of 40
Growth rate plus operating margin
48
88
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
15.4%
76
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+4.5%
73
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE HROW WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when HROW's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.